Articles From: AGCO’s Martin Richenhagen Selected as One of the Most Admired CEOs in the Atlanta Area to Agilysys and Compass Group North America Expand Partnership with Additional Deployment of Agilysys Elevate™ POS Solution


AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and solutions, announced today that Martin Richenhagen, Chairman, President and CEO of AGCO, was selected as one of 55 Most Admired CEOs by the Atlanta Business Chronicle.
Sign-up for AGCO’s Martin Richenhagen Selected as One of the Most Admired CEOs in the Atlanta Area investment picks
AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and solutions, announced that Richard Markwell, Vice President and Managing Director Massey Ferguson in Europe, Africa and Middle East (EAME), has been elected new President of CEMA, the association representing the producers of agricultural machinery in Europe.
Sign-up for AGCO’s Richard Markwell Elected New President of CEMA investment picks
Agenus Inc. (NASDAQ: AGEN), announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus’ Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.
Sign-up for Agenus Brain Cancer Vaccine Shows Extended Survival in Phase 2 Final Data Analysis investment picks
Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results and business highlights for the second quarter ended June 30, 2014.
Sign-up for Agenus Reports Second Quarter 2014 Financial Results investment picks
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced that Garo Armen, PhD, Chief Executive Officer, and Robert Stein, MD, PhD, Chief Scientific Officer, will conduct a series of one-on-one meetings with investors at the FBR Inaugural Healthcare Conference on Wednesday, September 3 in Boston.
Sign-up for Agenus to Participate in Two Upcoming Investor Conferences investment picks
Agenus Inc. (Nasdaq:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced that Robert Stein, MD, PhD, the company’s Chief Scientific Officer, will speak at Cambridge Healthtech Institute‘s Second Annual Conference on Immunomodulatory Therapeutic Antibodies For Cancer.
Sign-up for Agenus to Present at Cambridge Healthtech Institute’s Second Annual Conference on Immunomodulatory Therapeutic Antibodies for Cancer investment picks
Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced that Robert Stein, MD, PhD, the company’s Chief Scientific Officer, will present a company overview at the JMP Securities Healthcare Conference at the Westin Grand Central Hotel in New York City on Tuesday, June 24 th at 12:30 pm ET.
Sign-up for Agenus to Present at the JMP Securities Healthcare Conference investment picks
Agenus Inc. (NASDAQ: AGEN) will release its second quarter 2014 financial results before the market opens on July 24, 2014.
Sign-up for Agenus to Report Second Quarter 2014 Financial Results on July 24, 2014; Conference Call to Follow investment picks
Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced promising Phase 2 results for HerpV, a synthetic vaccine candidate for the treatment of patients with genital Herpes Simplex Virus-2 (HSV-2). HerpV contains a defined mixture of peptides representing HSV-2 antigens plus Agenus’ QS-21 Stimulon ® adjuvant.
Sign-up for Agenus Vaccine Shows Significant Reduction in Viral Burden after HerpV Generated Immune Activation investment picks
AGF Management Limited Reports Second Quarter Financial Results Canada NewsWire Adjusted earnings per share increased 30.8% TORONTO , June 24, 2014 /CNW/ - AGF Management Limited (AGF or the Company) today announced financial results for the second quarter ended May 31, 2014 , reporting diluted earnings per share (EPS) from continuing operations of $0.17 , compared to a loss of $0.12 for the three months ended May 31, 2013 .
Sign-up for AGF Management Limited Reports Second Quarter Financial Results investment picks
2014/9/15
AGF Management Limited to Release Third Quarter Results on September 24, 2014 Canada NewsWire TORONTO , Sept.
Sign-up for AGF Management Limited to Release Third Quarter Results on September 24, 2014 investment picks
AGF Reports August 2014 Assets Under Management Canada NewsWire TORONTO , Sept.
Sign-up for AGF Reports August 2014 Assets Under Management investment picks
2014/8/20
Aggreko, the global leader in temporary power generation , temperature control and oil-free compressed air solutions, has announced the winners of the 2014 Phil Harrower and Aggreko Merit Scholarships.
Sign-up for Aggreko Empowers Five Students with Scholarship Awards investment picks
2014/8/6
Aggreko, the global leader in temporary power generation and temperature control solutions , is providing large-scale power generation and climate control for the 2014 PGA Championship, taking place August 4-10 at Valhalla Golf Club in Louisville, KY.
Sign-up for Aggreko’s Hole-In-One Power and Cooling Services Supplies the 2014 PGA Championship investment picks
2014/9/11
By Chester Yung Agile Property Holdings Ltd.
Sign-up for Agile Property's Sales at CNY26.54 Billion in Jan-Aug Period investment picks
Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System PRINCETON, N.J. , July 17, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX) , a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance on July 17, 2014 for additional patent claims covering dosing regimens using the Company's lead product candidate Twirla™ (ethinyl estradiol and levonorgestrel transdermal system (AG200-15)), currently in Phase 3 development.
Sign-up for Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion® investment picks
Expands Patent Portfolio for its Contraceptive Patch, Twirla™ PRINCETON, N.J. , June 20, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX) , a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that patent U.S. 8,747,888 ('888 Patent), was issued by the U.S. Patent and Trademark Office on June 10, 2014 .
Sign-up for Agile Therapeutics Announces Issuance of New Patent for Its Skinfusion® Transdermal Delivery Device investment picks
PRINCETON, N.J. , June 30, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX) , a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced it has been added to the Russell Microcap Index.
Sign-up for Agile Therapeutics Joins Russell Microcap® Index investment picks
PRINCETON, N.J., Aug.
Sign-up for Agile Therapeutics Reports Second Quarter 2014 Financial Results investment picks
PRINCETON, N.J. , June 18, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX) , a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, the Company's Chief Executive Officer and President, will participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day on June 26, 2014 in Boston, MA.
Sign-up for Agile Therapeutics to Participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day investment picks
PRINCETON, N.J., Sept.
Sign-up for Agile Therapeutics to Ring the NASDAQ Stock Market Closing Bell investment picks
2014/9/2
Agilent Technologies Inc. (NYSE:A) today introduced the 7200B Quadrupole Time of Flight (Q-TOF) Gas Chromatography Mass Spectrometer (GC/MS) System .
Sign-up for Agilent Technologies Introduces Higher-Performance Q-TOF GC/MS System, Featuring Optimized Hardware/Software Capabilities investment picks
2014/9/2
Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML , the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute myeloid leukemia.
Sign-up for Agilent Technologies Introduces Next-Generation Sequencing Cancer Research Panels investment picks
2014/8/14
Agilent Technologies Inc. (NYSE: A) today reported orders of $1.74 billion, up 9 percent over one year ago, for the third fiscal quarter ended July 31, 2014, and revenues of $1.77 billion, up 7 percent compared with one year ago.
Sign-up for Agilent Technologies Reports Third-Quarter 2014 Results investment picks
2014/7/24
Agilent Technologies Inc. (NYSE:A) today announced it has extended a co-marketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services.
Sign-up for Agilent Technologies Signs Co-Marketing Agreement with MRM Proteomics to Advance Quantitative Proteomics Solutions investment picks
2014/7/31
Agilent Technologies Inc. (NYSE:A) today announced it will host two seminars at the Dioxin 2014 International Symposium in Madrid, Spain.
Sign-up for Agilent Technologies to Host Seminars at International Dioxin Symposium in Madrid investment picks
2014/7/31
Agilent Technologies Inc. (NYSE:A) will release third-quarter fiscal 2014 financial results after the stock market closes on Aug.
Sign-up for Agilent Technologies to Host Webcast of Third-Quarter Fiscal Year 2014 Financial Results Conference Call investment picks
2014/9/5
Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: Morgan Stanley Healthcare Conference Tuesday, Sept.
Sign-up for Agilent Technologies to Present at Morgan Stanley Healthcare Conference investment picks
Agilysys, Inc. (Nasdaq: AGYS), a leading provider of innovative information technology and hospitality software, and Compass Group North America, a leader in foodservice management and support services, today announced an expansion of their technology partnership as Compass Group rolls out the Agilysys Elevate™ POS solution to additional customer sites nationwide.
Sign-up for Agilysys and Compass Group North America Expand Partnership with Additional Deployment of Agilysys Elevate™ POS Solution investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AGCO’s Martin Richenhagen Selected as One of the Most Admired CEOs in the Atlanta Area to Agilysys and Compass Group North America Expand Partnership with Additional Deployment of Agilysys Elevate™ POS Solution
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices